Implantable Wafer Shows Promise for Preventing Glioblastoma Recurrence After Surgery
A biodegradable implant developed by researchers at Massachusetts General Hospital and Harvard Medical School may offer new hope for patients with glioblastoma, an aggressive brain cancer known for its high recurrence rate. The device, called the CANDI wafer, is designed […]
Implantable Wafer Shows Promise for Preventing Glioblastoma Recurrence After Surgery Read More »










